While the Framingham Heart Study has provided significant insights, there are limitations to consider. The original cohort was predominantly white, which may limit the generalizability of findings to more diverse populations. Additionally, the study was initially focused on cardiovascular health, so cancer-specific data may not be as comprehensive. However, these limitations do not diminish the study's overall contributions to medical research.
